- Number of people
- 150 (58.67% female)
- People with ≥2 records
- 3.33%
- Median duration from first to last measurement
- 0.26 years
Lepidoglyphus destructor IgE Ab [Units/volume] in Serum
Coding
Definition
- OMOP Concept ID
- 3000510— open in OHDSI Athena.
- Part of collection
- Lepidoglyphus destructor IgE with 0 other OMOP concept — open in OHDSI Athena.
OMOP mapping QC
| OMOP concept ID | Test name | Measurement unit (harmonized unit) | N people | N records | Missing measurement value | Harmonized value distribution |
Test outcome
NA
N
A
AA
L
LL
H
HH
|
|---|---|---|---|---|---|---|---|
| 3000510 | s-ldestre | u/ml (u/ml) | 78 | 81 | 9.88% |
|
|
| 3000510 | s-ldestre | — (—) | 73 | 74 | 100.00% | Distribution not available |
Cohort
- Number of people
- 150 (58.67% female)
Year of birth distribution
Age at first measurement
Age at last measurement
Age at start of registry
Duration from first to last measurement
Statistics
- People with ≥2 records
- 3.33%
- Median number of measurements per person
- 1.0
- Median duration from first to last measurement
- 0.26 years
Number of measurements over the years
Number of measurements per person
Distribution of lab values
Reference range
N people
N records
—
78
79
<0.35/KAIKKI
20
20
alle0.35/kaikki
18
18
0-0.35/KAIKKI
17
17
-ALLE0.35
16
17
Value range per person
LabWAS
Endpoint
People with measurements
Mean N measurements
Mean measured value
Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
86
59
12.87
83.31
1.0
1.0
0.23
0.94
u/ml
0.75
48
21
39
29
13.48
41.60
1.0
1.0
0.37
0.05
u/ml
0.72
20
11
31
41
3.83
8.48
1.1
1.0
0.13
0.06
u/ml
0.49
17
13
23
58
3.92
8.16
1.0
1.0
0.03
0.39
u/ml
1.01
14
25
39
73
2.68
6.33
1.0
1.1
0.17
0.38
u/ml
0.48
20
33
17
49
3.37
4.92
1.1
1.0
0.32
0.53
u/ml
—
7
20
24
90
1.98
2.40
1.0
1.0
0.50
0.58
u/ml
0.06
14
39
18
41
2.25
2.24
1.1
1.0
0.75
0.06
u/ml
—
6
13
20
66
1.91
1.82
1.0
1.0
0.35
0.70
u/ml
0.38
12
34
13
28
2.33
1.77
1.0
1.1
0.19
0.56
u/ml
—
5
10
27
114
1.56
1.31
1.0
1.0
0.46
0.27
u/ml
0.22
14
54
14
37
1.94
1.30
1.1
1.1
0.19
0.73
u/ml
—
6
19
25
104
1.54
1.16
1.0
1.0
0.33
0.50
u/ml
0.21
13
49
27
92
1.52
1.15
1.0
1.0
0.59
0.49
u/ml
—
10
48
17
51
1.67
1.04
1.1
1.0
0.22
0.34
u/ml
—
8
21
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
0
32
0.00
0.95
0.0
1.0
—
0.14
—
0
11
14
41
1.71
0.94
1.1
1.0
0.19
0.06
u/ml
—
5
13
22
101
1.47
0.90
1.0
1.0
1.60
0.39
u/ml
—
6
50
12
63
1.70
0.89
1.0
1.0
0.01
0.10
u/ml
—
6
27
16
123
0.71
0.63
1.0
1.0
0.30
0.39
u/ml
—
7
59
16
110
1.42
0.62
1.0
1.0
0.02
0.41
u/ml
—
10
50
12
41
1.53
0.58
1.0
1.0
1.88
0.06
u/ml
—
5
13
20
99
1.32
0.51
1.0
1.0
0.65
0.20
u/ml
—
10
45
13
124
0.72
0.51
1.1
1.0
1.97
0.34
u/ml
—
5
60
18
123
0.75
0.51
1.1
1.0
0.35
0.39
u/ml
—
8
59
27
120
1.26
0.48
1.0
1.0
0.17
0.51
u/ml
0.87
14
56
12
78
1.41
0.45
1.1
1.0
0.19
0.34
u/ml
—
7
33
15
69
1.35
0.43
1.0
1.0
0.12
0.46
u/ml
—
8
34
25
101
1.25
0.42
1.0
1.0
0.73
0.47
u/ml
—
9
49
0
15
0.00
0.41
0.0
1.1
—
0.25
—
0
6
12
110
0.75
0.38
1.1
1.0
0.13
0.45
u/ml
—
5
55
13
98
1.29
0.31
1.0
1.0
1.92
0.10
u/ml
—
6
45
14
121
0.80
0.30
1.0
1.0
0.68
0.44
u/ml
—
5
61
21
123
1.19
0.27
1.1
1.0
0.12
0.50
u/ml
1.10
12
57
15
125
0.82
0.27
1.0
1.0
1.54
0.28
u/ml
—
9
58
14
108
1.23
0.25
1.0
1.0
0.12
0.48
u/ml
—
5
53
15
116
1.19
0.21
1.0
1.0
0.32
0.34
u/ml
—
10
51
0
13
0.00
0.21
0.0
1.0
—
0.07
—
0
5
23
112
1.15
0.20
1.0
1.0
0.19
0.52
u/ml
0.83
13
55
0
14
0.00
0.20
0.0
1.1
—
0.05
—
0
5
11
118
0.84
0.17
1.1
1.0
1.18
0.27
u/ml
—
5
57
17
97
0.88
0.15
1.1
1.0
0.15
0.21
u/ml
—
7
43
18
84
1.14
0.14
1.1
1.0
0.75
0.47
u/ml
—
9
40
15
89
1.14
0.12
1.0
1.0
0.18
0.22
u/ml
—
7
41
14
118
1.09
0.06
1.0
1.0
0.12
0.43
u/ml
—
5
59
11
79
1.10
0.05
1.0
1.0
0.97
0.27
u/ml
—
5
35
14
88
0.96
0.00
1.0
1.0
1.74
0.28
u/ml
—
8
35
14
88
0.96
0.00
1.0
1.0
1.73
0.28
u/ml
—
8
35
11
71
0.97
0.00
1.0
1.0
0.11
0.43
u/ml
—
5
33
21
125
1.01
0.00
1.0
1.0
0.14
0.48
u/ml
—
8
61
19
107
0.97
0.00
1.1
1.0
0.16
0.46
u/ml
—
8
50
18
124
1.03
0.00
1.0
1.0
0.05
0.43
u/ml
—
8
59